Patented Drug Sector At Risk

BMI's view on the Jordanian pharmaceutical market is set to hold for the short term - generic drugs will continue to comprise the majority of the drug market owing to the developed local pharmaceutical production sector. As a more stable and market-friendly Arab country with rising revenues from medical tourism (which will drive private health and pharmaceutical spending) Jordan poses significant opportunities for multinational and regional players.

To read the full article, please choose one of the following options: